Form 4 for IRMD IRADIMED CORP
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-20 · accession 0001415889-25-018013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-23 | 2025-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | — | +5,796 | 14.6K | +66% | — |
| D | 2025-06-23 | 2025-06-20 | IRMD | GLENN JOHN | CFO | F - Tax | $58.24 | -1,412 | 13.2K | -10% | -$82.2K |
| D | 2025-06-23 | 2025-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | $0.00 | -5,796 | 5,796 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-20 | M | A | 5,796 | — | 14,563 | D | — | — | (F1) Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis. |
| 2 | Common | Common Stock | 2025-06-20 | F | D | 1,412 | $58.24 | 13,151 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-06-20 | M | D | 5,796 | $0.00 | 5,796 | D | — · — to — | 5,796 Common Stock | (F1) Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis. (F2) On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested. |